BIOTECHNOLOGY

Germany to boost the bioeconomy

Shortly before the Global Bioeconomy Summit (19.-20.4.2018) in Berlin will begin, Germany's new Research Minister Anja Karliczek announced three major initiatives to strengthen the biologisation of the industry and the...

Canopy acquires Czech Annabis Medical sro

Canopy Growth Corp. is growing its medical cannabis business in Europe with the acquisition of Czech market leader Annabis Medical sro. Unter the terms of the agreement, Canopy will...

Deinove acquires FDA-Fast Track antibiotic compound

French microbiology specialist Deinove has acquired Morphochem’s Phase II Clostridium difficile antibiotic MCB3837 as part of  its acquisition of the Austrian company Biovertis. Morphochem is Biovertis’ German subsidiary.  MCB3837 is...

GSK pass orphan gene therapy assets to Orchard Therapeutics

British drug major GlaxoSmithKline  (GSK) has passed its orphan autologous cell and gene therapy pipeline including its EU-approved ADA-SCID treatment Strimvelis to British/US Orchard Therapeutics. GSK acquired a 19,9% equity...

World Nutrition: Insects will be on every table

Bioeconomy: It could be a turning point for the fish meal and fish oil dependent animal feed industry in Europe. Since July, the European Commission has allowed the use of insect-processed...

Amsterdam applauded as new EMA headquarters

Amsterdam has beaten Milan and Copenhagen in the race to become the European Medicines Agency's new home. Pharma and biotech stakeholders applauded the vote as Amsterdam achieved the hightest rate...

CHMP recommends EU marketing approval of ten drugs

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended seven medicines for approval, including two orphan medicines, plus three generics at its November 2017 meeting.

FDA lifts clinical hold on Cellectis Phase I trials

The US Food and Drug Administration (FDA) has lifted the clinical hold due to a patient death on Phase I testing of UCART123 in acute myeloid leukemia (AML) and blastic...

European biotech stocks: New wave of optimism

In 2017, the European biotech sector witnessed a volume increase in IPOs and follow-on financings. This says the most recent capital market report of BIOCOM which is published during BIO-Europe...
Prev12Next
Biotechnology : nature.com


Nature Biotechnology journal featuring biotechnology articles and science research papers of commercial interest in pharmaceutical, medical, and environmental sciences.

A protein activity assay to measure global transcription factor activity...

A protein activity assay to measure global transcription factor activity reveals determinants of chromatin accessibilityA protein activity assay to measure global transcription factor activity reveals determinants of chromatin accessibility, Published...

High-throughput creation and functional profiling of DNA sequence variant libraries...

High-throughput creation and functional profiling of DNA sequence variant libraries using CRISPR–Cas9 in yeastHigh-throughput creation and functional profiling of DNA sequence variant libraries using CRISPR–Cas9 in yeast, Published online: 21...

Reversal of siRNA-mediated gene silencing <i>in vivo</i>

Reversal of siRNA-mediated gene silencing in vivoReversal of siRNA-mediated gene silencing <i>in vivo</i>, Published online: 14 May 2018; doi:10.1038/nbt.4136Gene silencing by siRNAs in vivo is reversed using sequence-specific high-affinity oligonucleotides.

Around the world in a month

Around the world in a monthAround the world in a month, Published online: 09 May 2018; doi:10.1038/nbt0518-385Around the world in a month

A rich resource

A rich resourceA rich resource, Published online: 09 May 2018; doi:10.1038/nbt.4130Employing graduate students and post-doctoral fellows in technology transfer groups

Trump threatens then signs, a win for FDA, NIH

Trump threatens then signs, a win for FDA, NIHTrump threatens then signs, a win for FDA, NIH, Published online: 09 May 2018; doi:10.1038/nbt0518-383Trump threatens then signs, a win for FDA,...

Allogene and Celularity move CAR-T therapy off the shelf

Allogene and Celularity move CAR-T therapy off the shelfAllogene and Celularity move CAR-T therapy off the shelf, Published online: 09 May 2018; doi:10.1038/nbt0518-375Allogene and Celularity move CAR-T therapy off the...

Unleashing biotech's crouching tiger

Unleashing biotech's crouching tigerUnleashing biotech's crouching tiger, Published online: 09 May 2018; doi:10.1038/nbt.4149With a massive expansion in healthcare coverage, biotech's next big boom could occur in India. But this revolution...